Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Luzi, L.
Right arrow Articles by Bretzel, R. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Luzi, L.
Right arrow Articles by Bretzel, R. G.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Diabetes 50:277-282, 2001
© 2001 by the American Diabetes Association, Inc.

Metabolic Effects of Restoring Partial ß-Cell Function After Islet Allotransplantation in Type 1 Diabetic Patients

Livio Luzi, Gianluca Perseghin, Mathias D. Brendel, Ileana Terruzzi, Alberto Battezzati, Michael Eckhard, Daniel Brandhorst, Heide Brandhorst, Schirin Friemann, Carlo Socci, Valerio Di Carlo, Lucia Piceni Sereni, Stefano Benedini, Antonio Secchi, Guido Pozza, and Reinhard G. Bretzel

From the Departments of Medicine and Surgery (L.L., G.Pe., I.T., A.B., C.S., V.D.C., L.P.S., S.B., A.S., G.P.), Istituto Scientifico H. San Raffaele and the University of Milan, Milan, Italy; and the Center of Internal Medicine (M.D.B., M.E., D.B., H.B., S.F., R.G.B.), Justus-Liebig Universität, Giessen, Germany.

Address correspondence and reprint requests to Dr. Livio Luzi, Head, Amino Acid and Stable Isotope Laboratory, Istituto Scientifico H. San Raffaele, via Olgettina 60, 20132 Milan, Italy. E-mail: luzi.livio{at}hsr.it .

Successful intraportal islet transplantation normalizes glucose metabolism in diabetic humans. To date, full function is not routinely achieved after islet transplantation in humans, with most grafts being characterized by only partial function. Moreover, the duration of full function is variable and cannot be sufficiently predicted with available methods. In contrast, most grafts retain partial function for a long time. We hypothesized that partial function can restore normal protein and lipid metabolism in diabetic individuals. We studied 45 diabetic patients after islet transplantation. Labeled glucose and leucine were infused to assess whole-body glucose and protein turnover in 1) 6 type 1 diabetic patients with full function after intraportal islet transplantation (FF group; C-peptide > 0.6 nmol/l; daily insulin dosage 0.03 ± 0.02 U · kg-1 body wt · day-1; fasting plasma glucose < 7.7 mmol/l; HbA1c <= 6.5%), 2) 17 patients with partial function (PF group; C-peptide > 0.16 nmol/l; insulin dosage < 0.4 U · kg-1 body wt · day-1), 3) 9 patients with no function (NF group; C-peptide < 0.16 nmol/l; insulin dosage > 0.4 U · kg-1 body wt · day-1), and 4) 6 patients with chronic uveitis as control subjects (CU group). Hepatic albumin synthesis was assessed in an additional five PF and five healthy volunteers by means of a primed-continuous infusion of [3,3,3-2H3]leucine. The insulin requirement was 97% lower than pretransplant levels for the FF group and 57% lower than pretransplant levels for the PF group. In the basal state, the PF group had a plasma glucose concentration slightly higher than that of the FF (P = 0.249) and CU groups (P = 0.08), but was improved with respect to the NF group (P < 0.01). Plasma leucine (101.1 ± 5.9 µmol/l) and branched-chain amino acids (337.6 ± 16.6 µmol/l) were similar in the PF, FF, and CU groups, and significantly lower than in the NF group (P < 0.01). During insulin infusion, the metabolic clearance rate of glucose was defective in the NF group versus in the other groups (P < 0.01). Both the basal and insulin-stimulated proteolytic and proteosynthetic rates were comparable in the PF, FF, and CU groups, but significantly higher in the NF group (P = 0.05). In addition, the PF group had a normal hepatic albumin synthesis. Plasma free fatty acid concentrations in the PF and FF groups were similar to those of the CU group, but the NF group showed a reduced insulin-dependent suppression during the clamp. We concluded that the restoration of ~60% of endogenous insulin secretion is capable of normalizing the alterations of protein and lipid metabolism in type 1 diabetic kidney recipients, notwithstanding chronic immunosuppressive therapy. The results of the present study indicate that "success" of islet transplantation may be best defined by a number of metabolic criteria, not just glucose concentration/metabolism alone.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Diabetes CareHome page
F. Bertuzzi and C. Ricordi
Prediction of Clinical Outcome in Islet Allotransplantation
Diabetes Care, February 1, 2007; 30(2): 410 - 417.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
P. Fiorina, M. Venturini, F. Folli, C. Losio, P. Maffi, C. Placidi, S. La Rosa, E. Orsenigo, C. Socci, C. Capella, et al.
Natural History of Kidney Graft Survival, Hypertrophy, and Vascular Function in End-Stage Renal Disease Type 1 Diabetic Kidney-Transplanted Patients: Beneficial impact of pancreas and successful islet cotransplantation
Diabetes Care, June 1, 2005; 28(6): 1303 - 1310.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
E. A. Ryan, B. W. Paty, P. A. Senior, J. R.T. Lakey, D. Bigam, and A.M. J. Shapiro
{beta}-Score: An assessment of {beta}-cell function after islet transplantation
Diabetes Care, February 1, 2005; 28(2): 343 - 347.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
M. Venturini, E. Angeli, P. Maffi, P. Fiorina, F. Bertuzzi, M. Salvioni, F. De Cobelli, C. Socci, L. Aldrighetti, C. Losio, et al.
Technique, Complications, and Therapeutic Efficacy of Percutaneous Transplantation of Human Pancreatic Islet Cells in Type 1 Diabetes: The Role of US
Radiology, February 1, 2005; 234(2): 617 - 624.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
R. P. Robertson
Islet Transplantation as a Treatment for Diabetes -- A Work in Progress
N. Engl. J. Med., February 12, 2004; 350(7): 694 - 705.
[Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
P. Fiorina, F. Folli, G. Zerbini, P. Maffi, C. Gremizzi, V. Di Carlo, C. Socci, F. Bertuzzi, M. Kashgarian, and A. Secchi
Islet Transplantation Is Associated with Improvement of Renal Function among Uremic Patients with Type I Diabetes Mellitus and Kidney Transplants
J. Am. Soc. Nephrol., August 1, 2003; 14(8): 2150 - 2158.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
P. Fiorina, F. Folli, F. Bertuzzi, P. Maffi, G. Finzi, M. Venturini, C. Socci, A. Davalli, E. Orsenigo, L. Monti, et al.
Long-Term Beneficial Effect of Islet Transplantation on Diabetic Macro-/Microangiopathy in Type 1 Diabetic Kidney-Transplanted Patients
Diabetes Care, April 1, 2003; 26(4): 1129 - 1136.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
A. Battezzati, S. Benedini, A. Fattorini, M. Losa, P. Mortini, S. Bertoli, R. Lanzi, G. Testolin, G. Biolo, and L. Luzi
Insulin action on protein metabolism in acromegalic patients
Am J Physiol Endocrinol Metab, April 1, 2003; 284(4): E823 - E829.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
L. Kessler, R. Passemard, J. Oberholzer, P. Y. Benhamou, P. Bucher, C. Toso, P. Meyer, A. Penfornis, L. Badet, P. Wolf, et al.
Reduction of Blood Glucose Variability in Type 1 Diabetic Patients Treated By Pancreatic Islet Transplantation: Interest of continuous glucose monitoring
Diabetes Care, December 1, 2002; 25(12): 2256 - 2262.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
E. A. Ryan, J. R.T. Lakey, B. W. Paty, S. Imes, G. S. Korbutt, N. M. Kneteman, D. Bigam, R. V. Rajotte, and A.M. J. Shapiro
Successful Islet Transplantation: Continued Insulin Reserve Provides Long-Term Glycemic Control
Diabetes, July 1, 2002; 51(7): 2148 - 2157.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2001 by the American Diabetes Association.